ACN
47
-5
WBA
43
-4
NOC
41
9
MDLZ
32
-4
DAL
84
-3
JNJ
41
3
XYL
35
-2
CSX
57
-4
ED
45
3
EW
32
3
FRT
41
-2
CSCO
58
-2
ICE
59
-3
CTAS
53
-3
TJX
62
-2
MMM
35
-5
THC
60
-5
MSI
72
-3
GLW
45
-3
STX
45
-4
ACN
47
-5
WBA
43
-4
NOC
41
9
MDLZ
32
-4
DAL
84
-3
JNJ
41
3
XYL
35
-2
CSX
57
-4
ED
45
3
EW
32
3
FRT
41
-2
CSCO
58
-2
ICE
59
-3
CTAS
53
-3
TJX
62
-2
MMM
35
-5
THC
60
-5
MSI
72
-3
GLW
45
-3
STX
45
-4
Financhill
Back

Agfa-Gevaert NV 10K Form

Sell
32

AFGVF
Agfa-Gevaert NV

Last Price:
1.10
Seasonality Move:
7.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AFGVF News And Ratings

See the #1 stock for the next 7 days that we like better than AFGVF

AFGVF Financial Statistics

Sales & Book Value

Annual Sales: $1.25B
Cash Flow: $-43.82M
Price / Cash Flow: 0
Annual Sales: $2.63
Price / Book: 0.42

Profitability

EPS (TTM): -0.26100
Net Income (TTM): $-39.14M
Gross Margin: $387.57M
Return on Equity: -8.97%
Return on Assets: -2.62%

Agfa-Gevaert NV Earnings Forecast

Key Agfa-Gevaert NV Financial Ratios

  • The Gross Profit Margin over the past 22 years for AFGVF is 31.13%.
  • The Selling, General & Administrative Expenses for AFGVF have been equal to 26.96% of Gross Profit Margin.
  • The Research & Development expenses have been 6.35% of Revenue.
  • The Interest Expense is -37.25% of Operating Income.
  • The Net Earning history of AFGVF is -8.87% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 13 years.

Agfa-Gevaert NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Technology
Sector: Health Care
Current Symbol: AFGVF
Website: agfa.com

Debt

Debt-to-Equity Ratio: 0.44
Current Ratio: 2.14
Quick Ratio: 1.14

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AFGVF Technical Analysis vs Fundamental Analysis

Sell
32
Agfa-Gevaert NV (AFGVF) is a Sell

Is Agfa-Gevaert NV a Buy or a Sell?

  • Agfa-Gevaert NV stock is rated a Sell
    The current Agfa-Gevaert NV [AFGVF] share price is $1.10. The Score for AFGVF is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.